Clinical trial

Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

NCT00335712 · Ono Pharma USA Inc, Industry · Completed

Key facts

NCT number NCT00335712
Title Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Official title Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Lead sponsor Ono Pharma USA Inc, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Type 2 Diabetes Mellitus
Intervention type Drug
Interventions ONO-5129
Enrollment 81
Start date Jun 1, 2006
First posted Jun 12, 2006
Last update posted Jun 13, 2012
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies